Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Verizon Communications Inc — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.39 (market cap $2.27B), while Verizon Communications Inc trades at $42.24 (market cap $192.57B). The key difference: Verizon Communications Inc is far larger — about 84.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Verizon Communications Inc pays a 6.11% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | VZ | |
|---|---|---|
Market Cap | $2.27B | $192.57B |
Volume | 4,179,659 | 20,940,094 |
Sector | Health | Media |
52-Week High | $15.46 | $51.45 |
52-Week Low | $1.39 | $38.40 |
Enterprise Value | $2.14B | $379.28B |
Typical Hold Time | — | 109 Days |
Dividend Yield | — | 6.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Verizon trades at $45.77, down 0.46% today, with a bearish technical outlook despite recent earnings beats. The stock shows solid fundamentals with a P/E of 12.07, ROE of 15.63%, and consistent dividend payments. Recent news highlights Verizon's joint venture with AT&T and T-Mobile to expand satellite connectivity and the election of Charles Phillips to the board. Cash flow improved significantly in 2025 with net cash flow of $14.9 billion.
Verizon offers value with reasonable valuation metrics and strong cash flow generation supporting its dividend. However, technical indicators signal bearish momentum, and revenue growth remains modest. The stock faces competitive pressures in the telecom sector and carries substantial long-term debt of $121.38 billion. Analyst consensus is mixed with 37.7% buy ratings but a price target of $48.58 suggesting modest upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
